X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lisdexamfetamine dimesylate (354) 354
index medicus (344) 344
humans (339) 339
psychiatry (229) 229
double-blind (221) 221
attention deficit disorder with hyperactivity - drug therapy (220) 220
male (190) 190
attention-deficit/hyperactivity disorder (186) 186
pharmacology & pharmacy (175) 175
adhd (174) 174
female (174) 174
central nervous system stimulants - therapeutic use (159) 159
adult (143) 143
attention-deficit hyperactivity disorder (135) 135
deficit hyperactivity disorder (134) 134
children (133) 133
attention deficit hyperactivity disorder (130) 130
child (130) 130
methylphenidate (130) 130
treatment outcome (128) 128
adolescent (124) 124
central nervous system stimulants - adverse effects (109) 109
efficacy (109) 109
dextroamphetamine - therapeutic use (108) 108
lisdexamfetamine (97) 97
drug therapy (95) 95
safety (90) 90
clinical neurology (88) 88
adults (85) 85
dextroamphetamine - adverse effects (81) 81
double-blind method (79) 79
neurosciences (77) 77
central nervous system stimulants - administration & dosage (75) 75
adolescents (71) 71
amphetamine (70) 70
pharmacotherapy (65) 65
dose-response relationship, drug (63) 63
middle aged (62) 62
dextroamphetamine - administration & dosage (61) 61
lisdexamfetamine dimesylate - therapeutic use (60) 60
open-label (59) 59
medicine & public health (57) 57
pediatrics (57) 57
young adult (57) 57
stimulants (56) 56
hyperactivity (54) 54
psychopharmacology (53) 53
analysis (52) 52
care and treatment (49) 49
attention deficit disorder with hyperactivity - psychology (48) 48
placebo-controlled trial (48) 48
research (48) 48
methylphenidate - therapeutic use (47) 47
atomoxetine (46) 46
extended-release (45) 45
amphetamines (43) 43
pharmacokinetics (42) 42
teenagers (41) 41
oros methylphenidate (40) 40
salts extended-release (40) 40
clinical trials (39) 39
dosage and administration (38) 38
pharmacology (38) 38
prevalence (38) 38
psychology, developmental (37) 37
animals (36) 36
comorbidity (36) 36
dimesylate (36) 36
medicine, general & internal (36) 36
attention deficit disorder with hyperactivity - diagnosis (35) 35
deficit/hyperactivity disorder (35) 35
neurology (35) 35
original (35) 35
psychiatric status rating scales (34) 34
stimulant (34) 34
deficit-hyperactivity disorder (33) 33
central nervous system stimulants - pharmacology (32) 32
lisdexamfetamine dimesylate - adverse effects (32) 32
drugs (31) 31
hyperactivity disorder (31) 31
mixed amphetamine salts (31) 31
studies (31) 31
randomized controlled trials as topic (30) 30
attention deficit disorder with hyperactivity - physiopathology (29) 29
binge-eating disorder - drug therapy (29) 29
controlled-trial (29) 29
mental disorders (29) 29
psychology, clinical (29) 29
atomoxetine hydrochloride (28) 28
dextroamphetamine - pharmacokinetics (28) 28
diagnosis (28) 28
health aspects (28) 28
internal medicine (28) 28
quality-of-life (28) 28
amphetamines - therapeutic use (27) 27
attention-deficit (27) 27
children & youth (27) 27
d-amphetamine (27) 27
dextroamphetamine - pharmacology (27) 27
methylphenidate - adverse effects (27) 27
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Drug Investigation, ISSN 1173-2563, 2008, Volume 28, Issue 12, pp. 745 - 755
.... It is important to understand the effects of pharmacological treatments of ADHD in adults. This study aimed to assess the absorption, metabolism and elimination of lisdexamfetamine dimesylate in normal, healthy adult subjects following a single oral dose... 
Lisdexamfetamine, pharmacokinetics | Central nervous system stimulants, pharmacokinetics | ADHD | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | PHARMACOKINETICS | ABUSE | FORMULATIONS | TOLERABILITY | DOUBLE-BLIND | METHYLPHENIDATE | PHARMACOLOGY & PHARMACY | SALTS EXTENDED-RELEASE | CHILDREN | Tissue Distribution | Dextroamphetamine - pharmacokinetics | Lisdexamfetamine Dimesylate | Humans | Middle Aged | Adult | Female | Male | Dextroamphetamine - adverse effects | Index Medicus
Journal Article
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2011, Volume 50, Issue 4, pp. 395 - 405
Journal Article
Journal Article
European Neuropsychopharmacology, ISSN 0924-977X, 2013, Volume 23, Issue 10, pp. 1208 - 1218
Abstract This study evaluated the efficacy and safety of lisdexamfetamine dimesylate (LDX... 
Internal Medicine | Psychiatry | Attention deficit disorder with hyperactivity | Lisdexamfetamine dimesylate | Prodrugs | Central nervous system stimulants | Child | Adolescent | ADHD | EFFICACY | SAFETY | PSYCHIATRY | DEFICIT HYPERACTIVITY DISORDER | ADULTS | NEUROSCIENCES | CLINICAL NEUROLOGY | GUIDELINE | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | CROSSOVER | D-AMPHETAMINE | Attention Deficit Disorder with Hyperactivity - physiopathology | Impulsive Behavior - etiology | Follow-Up Studies | Impulsive Behavior - prevention & control | Humans | Dextroamphetamine - therapeutic use | Male | Patient Dropouts | Dextroamphetamine - adverse effects | Dose-Response Relationship, Drug | Psychiatric Status Rating Scales | Central Nervous System Stimulants - therapeutic use | Lisdexamfetamine Dimesylate | Central Nervous System Stimulants - adverse effects | Female | Child Behavior - drug effects | Drug Resistance | Methylphenidate - chemistry | Severity of Illness Index | Methylphenidate - administration & dosage | Diagnostic and Statistical Manual of Mental Disorders | Double-Blind Method | Europe | Appetite Regulation - drug effects | Methylphenidate - adverse effects | Adolescent Behavior - drug effects | Attention Deficit Disorder with Hyperactivity - drug therapy | Methylphenidate - therapeutic use | Central Nervous System Stimulants - administration & dosage | Dextroamphetamine - administration & dosage | Medicine, Experimental | Medical research | Adolescence
Journal Article
International Journal of Eating Disorders, ISSN 0276-3478, 08/2017, Volume 50, Issue 8, pp. 884 - 892
Objective This study examined the time course of efficacy‐related endpoints for lisdexamfetamine dimesylate (LDX... 
time course | binge‐eating disorder | efficacy | lisdexamfetamine | binge-eating disorder | OBESITY | NUTRITION & DIETETICS | PSYCHIATRY | OBSESSIVE-COMPULSIVE SCALE | TOPIRAMATE | PSYCHOLOGY, CLINICAL | SIBUTRAMINE | PSYCHOLOGY | Original
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 2014, Volume 39, Issue 6, pp. 1388 - 1398
Journal Article
Journal Article
Journal Article